NASDAQ:BGLC | Operating Income | BioNexus Gene Lab Corp

Complete source-backed operating income history.

Available history
2018-06-30 to 2026-06-30
Data captured

Historical Operating Income

DateOperating Income
2026-06-30-$282,396.00
2026-03-31-$540,490.00
2025-12-31-$1.03M
2025-09-30-$702,509.00
2025-06-30-$611,293.00
2025-03-31-$618,418.00
2024-12-31-$416,220.00
2024-09-30-$1.34M
2024-06-30$259,168.00
2024-03-31-$79,028.00
2023-12-31$257,754.00
2023-09-30-$2.53M
2023-06-30-$272,199.00
2023-03-31-$50,631.00
2022-12-31-$122,689.00
2022-09-30-$65,215.00
2022-06-30-$137,964.00
2022-03-31$34,691.00
2021-12-31$201,063.00
2021-09-30$372,641.00
2021-06-30$139,990.00
2021-03-31$342,102.00
2020-12-31-$3,040.00
2020-09-30$237,306.00
2020-06-30-$33,974.00
2020-03-31$1.07M
2019-12-31-$96,145.00
2019-09-30-$50,138.00
2019-06-30-$69,219.00
2019-03-31-$60,203.00
2018-12-31-$63,346.00
2018-09-30-$55,142.00
2018-06-30-$39,472.00

Annual Operating Income

DateOperating Income
2025-12-31-$2.97M
2024-12-31-$1.57M
2023-12-31-$2.59M
2022-12-31-$291,177.00
2021-12-31$1.06M
2020-12-31$1.27M
2019-12-31-$275,705.00
2018-12-31$59,901.00